CO6140030A2 - Derivados de 4-bencilftalazinona 2-sustituidos como antagonistas de histamina h1 y h3 - Google Patents
Derivados de 4-bencilftalazinona 2-sustituidos como antagonistas de histamina h1 y h3Info
- Publication number
- CO6140030A2 CO6140030A2 CO08110028A CO08110028A CO6140030A2 CO 6140030 A2 CO6140030 A2 CO 6140030A2 CO 08110028 A CO08110028 A CO 08110028A CO 08110028 A CO08110028 A CO 08110028A CO 6140030 A2 CO6140030 A2 CO 6140030A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- formula
- bencilftalazinona
- derivatives
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1.- Un compuesto de fórmula (I)en la que A representa N o CH; R1 y R2 representan independientemente cada uno halógeno, alquilo C1-6, alcoxi C1-6, hidroxilo o trifluorometilo; y y z representan independientemente cada uno 0, 1 ó 2; R3 representa el grupo -(CH2)aNR4R5 o un grupo de fórmula (i)en la que a representa 1, 2 ó 3; b representa 0 ó 1; c representa 0, 1 ó 2 y d representa 0, 1, 2 ó 3, de tal modo que c y d no puedan ser ambos 0; R4 representa hidrógeno o alquilo C1-6; yR5 y R6 representan independientemente cada uno un grupo seleccionado de las fórmulas (a), (b) o (c)en las que, para la fórmula (a) e representa 1 a 6; e' representa 2 a 4; f representa 0, 1 ó 2 y g representa 0, 1, 2 ó 3, de tal modo que f y g no puedan ser ambos 0; h representa 0, 1 ó 2; R7 representa alquilo C1-3; en las que, para la fórmula (b) i representa 1 a 6; X representa un enlace, O ó -N(R10)C(O)-, en el que R10 representa hidrógeno o alquilo C1-6; j y k representan cada uno 1 o representan cada uno 2; R8 representa hidrógeno, cicloalquilo C3-6 o alquilo C1-6;en las que, para la fórmula (c) I representa 1 a 6; I' representa 0 a 3; m representa 0, 1 ó 2 y n representa 0, 1, 2 ó 3, de tal modo que m y n no puedan ser ambos 0, y de tal modo que I' más n deben representar 1, 2 ó 3;R9 representa hidrógeno, cicloalquilo C3-6 o alquilo C1-6; o una sal del mismo.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0607839A GB0607839D0 (en) | 2006-04-20 | 2006-04-20 | Compounds |
| GB0706176A GB0706176D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
| GB0706160A GB0706160D0 (en) | 2007-03-29 | 2007-03-29 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6140030A2 true CO6140030A2 (es) | 2010-03-19 |
Family
ID=38226516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO08110028A CO6140030A2 (es) | 2006-04-20 | 2008-10-15 | Derivados de 4-bencilftalazinona 2-sustituidos como antagonistas de histamina h1 y h3 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20090105225A1 (es) |
| EP (1) | EP2007735B1 (es) |
| JP (1) | JP4489143B2 (es) |
| KR (1) | KR20090007604A (es) |
| AR (1) | AR060535A1 (es) |
| AT (1) | ATE486063T1 (es) |
| AU (1) | AU2007242842A1 (es) |
| BR (1) | BRPI0710156A2 (es) |
| CA (1) | CA2649029A1 (es) |
| CO (1) | CO6140030A2 (es) |
| CR (1) | CR10356A (es) |
| DE (1) | DE602007010118D1 (es) |
| EA (1) | EA200801996A1 (es) |
| MA (1) | MA30405B1 (es) |
| MX (1) | MX2008013406A (es) |
| NO (1) | NO20084363L (es) |
| PE (1) | PE20080360A1 (es) |
| TW (1) | TW200811116A (es) |
| WO (1) | WO2007122156A1 (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200730498A (en) | 2005-12-20 | 2007-08-16 | Glaxo Group Ltd | Compounds |
| JP2010513393A (ja) * | 2006-12-20 | 2010-04-30 | グラクソ グループ リミテッド | Ｈ１受容体アンタゴニストとしての４−ベンジル−ｌ（２ｈ）−フタラジノン |
| PE20091089A1 (es) * | 2007-10-16 | 2009-08-24 | Glaxo Group Ltd | Composiciones farmaceuticas que comprenden 4-[(4-clorofenil)metil]-2-({(2r)-1-[4-(4{[3-(hexahidro-1h-azepin-1-il)propil]oxi}fenil)butil]-2-pirrolidinil}metil)-1(2h)-ftalazinona y furoato de fluticasona |
| AU2009325091A1 (en) | 2008-05-23 | 2010-06-17 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein inhibitor |
| GB0811447D0 (en) * | 2008-06-20 | 2008-07-30 | Glaxo Group Ltd | Formulations |
| WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
| EP2448586A1 (en) * | 2009-06-29 | 2012-05-09 | Glaxo Group Limited | New medical use |
| US9206146B2 (en) | 2010-05-19 | 2015-12-08 | Sandoz Ag | Purification of posaconazole and of posaconazole intermediates |
| JP2013532131A (ja) | 2010-05-19 | 2013-08-15 | サンド・アクチエンゲゼルシヤフト | ポサコナゾール中間体の製造 |
| JP5956980B2 (ja) | 2010-05-19 | 2016-07-27 | サンド・アクチエンゲゼルシヤフト | キラル化合物の調製の方法 |
| WO2012045729A1 (en) | 2010-10-05 | 2012-04-12 | Glaxo Group Limited | Imidazo [1, 2 -a] pyridine and pyrazolo [1, 5 -a] pyridine derivatives as trpv1 antagonists |
| WO2012072512A1 (en) | 2010-11-29 | 2012-06-07 | Glaxo Group Limited | N-cyclobutyl-imidazopyridine or -pyrazolopyridine carboxamides as trpv1 antagonists |
| US8754101B2 (en) | 2011-04-11 | 2014-06-17 | Glaxo Group Limited | N-cyclobutyl-imidazopyridine-methylamine as TRPV1 antagonists |
| CN103635465A (zh) | 2011-06-16 | 2014-03-12 | 桑多斯股份公司 | 制备手性化合物的方法 |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| MX2016014859A (es) | 2014-05-12 | 2017-06-27 | Glaxosmithkline Intellectual Property (No 2) Ltd | Composiciones farmaceuticas que comprenden danirixina para tratar enfermedades infecciosas. |
| EP4125919A1 (en) | 2020-03-26 | 2023-02-08 | GlaxoSmithKline Intellectual Property Development Limited | Cathepsin inhibitors for preventing or treating viral infections |
| EP4346815A1 (en) * | 2021-05-27 | 2024-04-10 | Schrödinger, Inc. | Heterocyclic compounds and methods of use |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH572914A5 (es) * | 1971-01-22 | 1976-02-27 | Asta Werke Ag Chem Fab | |
| US3813384A (en) * | 1972-01-17 | 1974-05-28 | Asta Werke Ag Chem Fab | Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof |
| EP0174464B1 (de) * | 1984-09-14 | 1990-01-03 | ASTA Pharma AG | Substituierte Benzylphthalazinon-Derivate |
| EP0222191B1 (de) * | 1985-11-11 | 1991-01-30 | ASTA Pharma AG | 4-Benzyl-1-(2H)-phthalazinon-Derivate |
| EP0289939A1 (de) * | 1987-05-08 | 1988-11-09 | ASTA Pharma AG | Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest |
| CZ199593A3 (en) * | 1992-10-02 | 1994-04-13 | Asta Medica Ag | Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr) |
| US6180629B1 (en) * | 1998-08-14 | 2001-01-30 | Cell Pathways, Inc. | [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia |
| DK0997474T3 (da) * | 1998-08-14 | 2004-02-09 | Pfizer | Antithrombotiske midler |
| GB0224084D0 (en) * | 2002-10-16 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| CN1787818A (zh) * | 2003-03-18 | 2006-06-14 | 麦克公司 | 趋化因子受体活性的氨基环丁基酰胺调节剂 |
| JP4735261B2 (ja) * | 2003-06-27 | 2011-07-27 | Ｍｓｄ株式会社 | ヘテロアリールオキシ含窒素飽和ヘテロ環誘導体 |
-
2007
- 2007-04-18 DE DE602007010118T patent/DE602007010118D1/de active Active
- 2007-04-18 AT AT07728235T patent/ATE486063T1/de not_active IP Right Cessation
- 2007-04-18 CA CA002649029A patent/CA2649029A1/en not_active Abandoned
- 2007-04-18 EA EA200801996A patent/EA200801996A1/ru unknown
- 2007-04-18 AR ARP070101668A patent/AR060535A1/es not_active Application Discontinuation
- 2007-04-18 TW TW096113665A patent/TW200811116A/zh unknown
- 2007-04-18 MX MX2008013406A patent/MX2008013406A/es not_active Application Discontinuation
- 2007-04-18 US US12/297,458 patent/US20090105225A1/en not_active Abandoned
- 2007-04-18 PE PE2007000478A patent/PE20080360A1/es not_active Application Discontinuation
- 2007-04-18 WO PCT/EP2007/053773 patent/WO2007122156A1/en active Application Filing
- 2007-04-18 JP JP2009505878A patent/JP4489143B2/ja not_active Expired - Fee Related
- 2007-04-18 AU AU2007242842A patent/AU2007242842A1/en not_active Abandoned
- 2007-04-18 EP EP07728235A patent/EP2007735B1/en active Active
- 2007-04-18 KR KR1020087028456A patent/KR20090007604A/ko not_active Application Discontinuation
- 2007-04-18 BR BRPI0710156-2A patent/BRPI0710156A2/pt not_active Application Discontinuation
- 2007-04-18 US US11/736,602 patent/US20080039444A1/en not_active Abandoned
-
2008
- 2008-10-07 CR CR10356A patent/CR10356A/es not_active Application Discontinuation
- 2008-10-15 CO CO08110028A patent/CO6140030A2/es unknown
- 2008-10-17 NO NO20084363A patent/NO20084363L/no not_active Application Discontinuation
- 2008-11-10 MA MA31370A patent/MA30405B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2008013406A (es) | 2008-11-04 |
| ATE486063T1 (de) | 2010-11-15 |
| JP4489143B2 (ja) | 2010-06-23 |
| EP2007735B1 (en) | 2010-10-27 |
| AU2007242842A1 (en) | 2007-11-01 |
| CA2649029A1 (en) | 2007-11-01 |
| EP2007735A1 (en) | 2008-12-31 |
| WO2007122156A9 (en) | 2008-01-24 |
| JP2009534351A (ja) | 2009-09-24 |
| NO20084363L (no) | 2008-11-17 |
| EA200801996A1 (ru) | 2009-04-28 |
| TW200811116A (en) | 2008-03-01 |
| US20090105225A1 (en) | 2009-04-23 |
| BRPI0710156A2 (pt) | 2012-06-05 |
| AR060535A1 (es) | 2008-06-25 |
| DE602007010118D1 (de) | 2010-12-09 |
| US20080039444A1 (en) | 2008-02-14 |
| PE20080360A1 (es) | 2008-05-22 |
| MA30405B1 (fr) | 2009-05-04 |
| CR10356A (es) | 2008-11-26 |
| KR20090007604A (ko) | 2009-01-19 |
| WO2007122156A1 (en) | 2007-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6140030A2 (es) | Derivados de 4-bencilftalazinona 2-sustituidos como antagonistas de histamina h1 y h3 | |
| ECSP099324A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1 | |
| ECSP099755A (es) | Derivados de pirrolopiridina y su uso como inhibidores de bace | |
| PE20151509A1 (es) | Derivado de piridina monociclico | |
| AR056536A1 (es) | Compuestos de 2-amino-5- [4-(difluormetoxi)fenil]-5-fenilimidazolona como inhibidores de la beta secretasa (bace) | |
| MX2011011875A (es) | Compuesto de carboxamida heterociclica diamino. | |
| RS54260B1 (en) | AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT | |
| AR065280A1 (es) | Agentes antiparasitarios | |
| AR071763A1 (es) | Pirazoles trisustituidos, composiciones farmaceuticas que los contienen, y usos de los mismos en el tratamiento de trastornos neurologicos y psiquiatricos | |
| CO6321168A2 (es) | Nuevos derivados de 2-amidotiadiazol | |
| ATE466842T1 (de) | 3-substituierte pyridinderivate als h3- antagonisten | |
| PE20110405A1 (es) | Derivados de piridino-piridinonas como inhibidores de la actividad de la tirosina quinasa de pdgf-r y/o flt-3 y su preparacion | |
| UA117151C2 (uk) | N-ациліміногетероциклічні сполуки | |
| AR076008A1 (es) | Derivados de hidroximetil-isoxazol moduladores de receptores gaba a, composiciones farmaceuticas que los contienen, metodo para prepararlos y uso de los mismos para el tratamiento del alzheimer y otros trastornos cognitivos. | |
| AR070485A1 (es) | Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica | |
| AR061520A1 (es) | Derivados de cinamoil-piperazina | |
| AR059710A1 (es) | Arilsulfonamidas sustituidas | |
| PE20081665A1 (es) | Antagonistas del receptor de dopamina 2 de rapida disociacion | |
| CO6341610A2 (es) | Compuesto heterociclilo aromatico que contiene nitrogeno. | |
| ATE446089T1 (de) | 2-benzoyl-imidazopyridin-derivate, herstellungsverfahren und ihre verwendung für therapeutika | |
| AR076692A1 (es) | Piperidinas sustituidas | |
| NO20080033L (no) | Kinolinderivater som NK3-antagonister | |
| MX2009010727A (es) | Heterociclos como antagonistas de orexina. | |
| PE20091450A1 (es) | INHIBIDORES DE LA ESTEAROIL-CoA-DESATURASA | |
| AR120404A1 (es) | CARBOXAMIDAS HETEROCÍCLICAS SUSTITUIDAS COMO ANTAGONISTAS DE LOS RECEPTORES a₂C ADRENÉRGICOS |